{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:20:59Z","timestamp":1789676459315,"version":"4.0.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To observe the effect of different antiemetic drugs for the prevention of postoperative nausea and vomiting (PONV) after gynaecological day surgery under remimazolam general anesthesia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>One hundred ninety-two patients were selected for gynaecological day surgery and randomly divided into three groups: droperidol group (DD group), tropisetron group (DT group) and control group (DC group). Flurbiprofen axetil 50\u00a0mg and dexamethasone 5\u00a0mg were given intravenously before induction of anesthesia, and 2\u00a0min later droperidol 1\u00a0mg was given intravenously to the DD group, tropisetron 5\u00a0mg to the DT group and saline (5\u00a0ml) to the DC group. Induction of anesthesia: remimazolam 6\u00a0mg\/kg\/h was continuously infused until sleep, mivacurium 0.2\u00a0mg\/kg and alfentanil 20ug\/kg were slowly pushed, 3\u00a0min later intubation was performed to control breathing. Maintenance of anesthesia: 40ug\/kg\/h of alfentanil, 1\u00a0mg\/kg\/h of remimazolam continuous infusion. After awakening and extubation, the patient was transferred to the PACU. PONV were recorded in the PACU and an electronic questionnaire was pushed 24\u00a0h after surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The incidence of PONV within the PACU was significantly lower in the DD (14.5%)and DT(26.7%) groups than in the DC(50%) group (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01), there was no significantly difference between the DT and DD groups. There were no significant difference in the incidence of PONV in 24\u00a0h after surgery between the three groups(DD:DT:DC\u2009=\u200944.5%:45.1%:63.8%,<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Droperidol or tropisetron combined with dexamethasone is superior to dexamethasone alone for the prevention of PONV in the PACU after remimazolam combined with alfentanil anesthesia, with no significant difference in the incidence of PONV in 24\u00a0h after surgery.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12871-022-01835-x","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T05:02:52Z","timestamp":1663218172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Prevention of postoperative nausea and vomiting after gynaecological day surgery under remimazolam general anesthesia: a randomized double-blind controlled study"],"prefix":"10.1186","volume":"22","author":[{"given":"Fuxia","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanceng","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,15]]},"reference":[{"issue":"2","key":"1835_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00540-022-03041-y","volume":"36","author":"Y Hari","year":"2022","unstructured":"Hari Y, Satomi S, Murakami C, et al. Remimazolam decreased the incidence of early postoperative nausea and vomiting compared to desflurane after laparoscopic gynecological surgery. J Anesth. 2022;36(2):265\u20139. https:\/\/doi.org\/10.1007\/s00540-022-03041-y.","journal-title":"J Anesth."},{"issue":"4","key":"1835_CR2","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/ACO.0000000000000877","volume":"33","author":"JR Sneyd","year":"2020","unstructured":"Sneyd JR, Rigby-Jones AE. Remimazolam for anaesthesia or sedation. Curr Opin Anaesthesiol. 2020;33(4):506\u201311. https:\/\/doi.org\/10.1097\/ACO.0000000000000877.","journal-title":"Curr Opin Anaesthesiol."},{"issue":"24","key":"1835_CR3","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1056\/NEJMe048099","volume":"350","author":"PF White","year":"2004","unstructured":"White PF. Prevention of postoperative nausea and vomiting\u2013a multimodal solution to a persistent problem. N Engl J Med. 2004;350(24):2511\u20132. https:\/\/doi.org\/10.1056\/NEJMe048099.","journal-title":"N Engl J Med."},{"issue":"1","key":"1835_CR4","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12871-021-01373-y","volume":"21","author":"X Zhang","year":"2021","unstructured":"Zhang X, Li S, Liu J. Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial. BMC Anesthesiol. 2021;21(1):156. https:\/\/doi.org\/10.1186\/s12871-021-01373-y.","journal-title":"BMC Anesthesiol"},{"issue":"1","key":"1835_CR5","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12871-022-01713-6","volume":"22","author":"J Guo","year":"2022","unstructured":"Guo J, Qian Y, Zhang X, Han S, Shi Q, Xu J. Remimazolam tosilate compared with propofol for gastrointestinal endoscopy in elderly patients: a prospective, randomized and controlled study. BMC Anesthesiol. 2022;22(1):180. https:\/\/doi.org\/10.1186\/s12871-022-01713-6.","journal-title":"BMC Anesthesiol"},{"issue":"2","key":"1835_CR6","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1213\/ANE.0b013e31823f0c28","volume":"115","author":"Antonik","year":"2012","unstructured":"Antonik, Laurie J, et al. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics. Anesthesia and analgesia. 2012;115(2):274\u201383. https:\/\/doi.org\/10.1213\/ANE.0b013e31823f0c28.","journal-title":"Anesthesia and analgesia"},{"issue":"2","key":"1835_CR7","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1213\/ANE.0b013e318241f68a","volume":"115","author":"HR Wiltshire","year":"2012","unstructured":"Wiltshire HR, Kilpatrick GJ, Tilbrook GS, Borkett KM. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation. Anesth Analg. 2012;115(2):284\u201396. https:\/\/doi.org\/10.1213\/ANE.0b013e318241f68a.","journal-title":"Anesth Analg."},{"issue":"4","key":"1835_CR8","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.clinthera.2020.02.006","volume":"42","author":"X Chen","year":"2020","unstructured":"Chen X, Sang N, Song K, et al. Psychomotor Recovery Following Remimazolam-induced Sedation and the Effectiveness of Flumazenil as an Antidote. Clin Ther. 2020;42(4):614\u201324. https:\/\/doi.org\/10.1016\/j.clinthera.2020.02.006.","journal-title":"Clin Ther"},{"issue":"4","key":"1835_CR9","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00540-020-02755-1","volume":"34","author":"K Masui","year":"2020","unstructured":"Masui K. Remimazolam besilate, a benzodiazepine, has been approved for general anesthesia!! J Anesth. 2020;34(4):479\u201382. https:\/\/doi.org\/10.1007\/s00540-020-02755-1.","journal-title":"J Anesth."},{"issue":"10","key":"1835_CR10","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.23736\/S0375-9393.21.15517-8","volume":"87","author":"G Dai","year":"2021","unstructured":"Dai G, Pei L, Duan F, et al. Safety and efficacy of remimazolam compared with propofol in induction of general anesthesia. Minerva Anestesiol. 2021;87(10):1073\u20139. https:\/\/doi.org\/10.23736\/S0375-9393.21.15517-8.","journal-title":"Minerva Anestesiol."},{"issue":"5","key":"1835_CR11","doi-asserted-by":"publisher","first-page":"e00851","DOI":"10.1002\/prp2.851","volume":"9","author":"T Liu","year":"2021","unstructured":"Liu T, Lai T, Chen J, et al. Effect of remimazolam induction on hemodynamics in patients undergoing valve replacement surgery: A randomized, double-blind, controlled trial. Pharmacol Res Perspect. 2021;9(5):e00851. https:\/\/doi.org\/10.1002\/prp2.851.","journal-title":"Pharmacol Res Perspect."},{"issue":"4","key":"1835_CR12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00540-020-02776-w","volume":"34","author":"M Doi","year":"2020","unstructured":"Doi M, Hirata N, Suzuki T, Morisaki H, Morimatsu H, Sakamoto A. Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial. J Anesth. 2020;34(4):491\u2013501. https:\/\/doi.org\/10.1007\/s00540-020-02776-w.","journal-title":"J Anesth."},{"issue":"4","key":"1835_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/jcph.1552","volume":"60","author":"LL Lohmer","year":"2020","unstructured":"Lohmer LL, Schippers F, Petersen KU, Stoehr T, Schmith VD. Time-to-Event Modeling for Remimazolam for the Indication of Induction and Maintenance of General Anesthesia. J Clin Pharmacol. 2020;60(4):505\u201314. https:\/\/doi.org\/10.1002\/jcph.1552.","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"1835_CR14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jopan.2020.10.004","volume":"36","author":"G Mara\u015f","year":"2021","unstructured":"Mara\u015f G, Bulut H. Prevalence of Nausea-Vomiting and Coping Strategies in Patients Undergoing Outpatient Surgery. J Perianesth Nurs. 2021;36(5):487\u201391. https:\/\/doi.org\/10.1016\/j.jopan.2020.10.004.","journal-title":"J Perianesth Nurs."},{"issue":"4","key":"1835_CR15","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.bpa.2020.10.008","volume":"34","author":"M Dziadzko","year":"2020","unstructured":"Dziadzko M, Aubrun F. Management of postdischarge nausea and vomiting. Best Pract Res Clin Anaesthesiol. 2020;34(4):771\u20138. https:\/\/doi.org\/10.1016\/j.bpa.2020.10.008.","journal-title":"Best Pract Res Clin Anaesthesiol."},{"issue":"6","key":"1835_CR16","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.ijom.2015.01.006","volume":"44","author":"C Phillips","year":"2015","unstructured":"Phillips C, Brookes CD, Rich J, Arbon J, Turvey TA. Postoperative nausea and vomiting following orthognathic surgery. Int J Oral Maxillofac Surg. 2015;44(6):745\u201351. https:\/\/doi.org\/10.1016\/j.ijom.2015.01.006.","journal-title":"Int J Oral Maxillofac Surg."},{"key":"1835_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ijsu.2015.01.024","volume":"15","author":"E \u00d6brink","year":"2015","unstructured":"\u00d6brink E, Jildenst\u00e5l P, Oddby E, Jakobsson JG. Post-operative nausea and vomiting: update on predicting the probability and ways to minimize its occurrence, with focus on ambulatory surgery. Int J Surg. 2015;15:100\u20136. https:\/\/doi.org\/10.1016\/j.ijsu.2015.01.024.","journal-title":"Int J Surg."},{"issue":"2","key":"1835_CR18","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1213\/ane.0b013e31817b842c","volume":"107","author":"PF White","year":"2008","unstructured":"White PF, O\u2019Hara JF, Roberson CR, Wender RH, Candiotti KA, POST-OP Study Group. The impact of current antiemetic practices on patient outcomes: a prospective study on high-risk patients. Anesth Analg. 2008;107(2):452\u20138. https:\/\/doi.org\/10.1213\/ane.0b013e31817b842c.","journal-title":"Anesth Analg."},{"issue":"9","key":"1835_CR19","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1111\/aas.13936","volume":"65","author":"E Johansson","year":"2021","unstructured":"Johansson E, Hultin M, Myrberg T, Walld\u00e9n J. Early post-operative nausea and vomiting: A retrospective observational study of 2030 patients. Acta Anaesthesiol Scand. 2021;65(9):1229\u201339. https:\/\/doi.org\/10.1111\/aas.13936.","journal-title":"Acta Anaesthesiol Scand."},{"key":"1835_CR20","doi-asserted-by":"publisher","first-page":"7089454","DOI":"10.1155\/2016\/7089454","volume":"2016","author":"S Maitra","year":"2016","unstructured":"Maitra S, Som A, Baidya DK, Bhattacharjee S. Comparison of Ondansetron and Dexamethasone for Prophylaxis of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Surgeries: A Meta-Analysis of Randomized Controlled Trials. Anesthesiol Res Pract. 2016;2016:7089454. https:\/\/doi.org\/10.1155\/2016\/7089454.","journal-title":"Anesthesiol Res Pract."},{"issue":"3","key":"1835_CR21","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/ALN.0b013e318267ef31","volume":"117","author":"CC Apfel","year":"2012","unstructured":"Apfel CC, Philip BK, Cakmakkaya OS, et al. Who is at risk for postdischarge nausea and vomiting after ambulatory surgery? Anesthesiology. 2012;117(3):475\u201386. https:\/\/doi.org\/10.1097\/ALN.0b013e318267ef31.","journal-title":"Anesthesiology."},{"issue":"4","key":"1835_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/BF03018234","volume":"51","author":"AS Habib","year":"2004","unstructured":"Habib AS, El-Moalem HE, Gan TJ. The efficacy of the 5-HT3 receptor antagonists combined with droperidol for PONV prophylaxis is similar to their combination with dexamethasone. A meta-analysis of randomized controlled trials. Can J Anaesth. 2004;51(4):311\u20139. https:\/\/doi.org\/10.1007\/BF03018234.","journal-title":"Can J Anaesth."},{"issue":"1","key":"1835_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1034\/j.1399-6576.2001.450102.x","volume":"45","author":"MR Tram\u00e8r","year":"2001","unstructured":"Tram\u00e8r MR. A rational approach to the control of postoperative nausea and vomiting: evidence from systematic reviews. Part I. Efficacy and harm of antiemetic interventions, and methodological issues. Acta Anaesthesiol Scand. 2001;45(1):4\u201313. https:\/\/doi.org\/10.1034\/j.1399-6576.2001.450102.x.","journal-title":"Acta Anaesthesiol Scand."},{"issue":"4","key":"1835_CR24","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00540-017-2363-x","volume":"31","author":"X Cao","year":"2017","unstructured":"Cao X, White PF, Ma H. An update on the management of postoperative nausea and vomiting. J Anesth. 2017;31(4):617\u201326. https:\/\/doi.org\/10.1007\/s00540-017-2363-x.","journal-title":"J Anesth."},{"issue":"3","key":"1835_CR25","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1213\/ANE.0000000000001062","volume":"122","author":"EJ Ahn","year":"2016","unstructured":"Ahn EJ, Kang H, Choi GJ, Baek CW, Jung YH, Woo YC. The Effectiveness of Midazolam for Preventing Postoperative Nausea and Vomiting: A Systematic Review and Meta-Analysis. Anesth Analg. 2016;122(3):664\u201376. https:\/\/doi.org\/10.1213\/ANE.0000000000001062.","journal-title":"Anesth Analg."},{"issue":"1","key":"1835_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.17085\/apm.21115","volume":"17","author":"KM Kim","year":"2022","unstructured":"Kim KM. Remimazolam: pharmacological characteristics and clinical applications in anesthesiology. Anesth Pain Med (Seoul). 2022;17(1):1\u201311. https:\/\/doi.org\/10.17085\/apm.21115.","journal-title":"Anesth Pain Med (Seoul)."}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-022-01835-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-022-01835-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-022-01835-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T05:03:04Z","timestamp":1663218184000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-022-01835-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,15]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1835"],"URL":"https:\/\/doi.org\/10.1186\/s12871-022-01835-x","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,15]]},"assertion":[{"value":"3 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Clinical Research Ethics Committee of Weifang People\u2019s Hospital (2021029) and registered at  (ChiCTR2100053316). The study protocol followed the CONSORT guidelines. The study protocol was performed in the relevant guidelines. Written informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"292"}}